The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value – an Evaluation of Rosuvastatin therapY compared with atorvastatin

By Fonseca Francisco A. H.   Ruiz Alvaro   Cardona-Muñoz Ernesto G.   Silva Jose M.   Fuenmayor Nery   Marotti Marcelo  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1307-1316

Informa Healthcare

Access to resources Recommend Favorite

LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study

By Jukema J. Wouter   Liem An-Ho   Dunselman Peter H. J. M.   van der Sloot Jos A. P.   Lok Dirk J. A.   Zwinderman Aeilko H.  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1865-1874

Informa Healthcare

Access to resources Recommend Favorite

A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study

By Farsang C.   Athyros V.   Gaw A.    

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1945-1956

Informa Healthcare

Access to resources Recommend Favorite

Non-HDL cholesterol, ApoB and LDL particle concentration in coronary heart disease risk prediction and treatment

By Orringer Carl E  

Clinical Lipidology, Vol. 8, Iss. 1, 2013-02 ,pp. : 69-79

Future Medicine

Access to resources Recommend Favorite

Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice

By Gandhi Sanjay K.   Järbrink Krister   Fox Kathleen M.   Brandrup-Wognsen Gunnar  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2817-2828

Informa Healthcare

Access to resources Recommend Favorite